Document:

EX-10.2

 Exhibit 10.2 

TERMINATION OF LEASE 

THIS TERMINATION OF LEASE (this “Agreement”) is entered into as of September 15, 2014, by and between THIRTY-EIGHT
SIDNEY STREET LIMITED PARTNERSHIP, a Delaware limited partnership (“Landlord”), and AGIOS PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”). 

Capitalized terms used herein and not otherwise defined shall have the meaning ascribed to such term in the Lease (as defined below). 

W I T N E S S E T H 
 WHEREAS,
Landlord and Tenant entered into a certain Lease dated as of August 2, 2010 (the “38 Lease”), for certain premises containing approximately 38,536 rentable square feet located on the second and third floors of the building at
38 Sidney Street, Cambridge, Massachusetts (the “Premises”); 
 WHEREAS, the Initial Term of the 38 Lease expires on
April 30, 2016 (the “38 Lease Expiration”); 
 WHEREAS, Tenant has entered into a new lease with an affiliate of
Landlord at the building located at 88 Sidney Street, Cambridge, Massachusetts (the “88 Lease”); and 
 WHEREAS, Tenant and
Landlord desire to terminate the 38 Lease prior to the 38 Lease Expiration, as set forth in this Agreement. 
 NOW, THEREFORE, in
consideration of the promises and mutual covenants hereinafter contained and other valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Landlord and Tenant hereby agree as follows: 

 

	 	1.	So long as there is no default under and continuing by Tenant, the 38 Lease shall be terminated effective thirty (30) days after the rent commencement date under the terms of the 88 Lease (the “88 Rent
Commencement Date”), which 88 Rent Commencement Date shall be on or about May 1, 2015 (such termination date being the “38 Termination Date”). 

 

	 	2.	Within thirty (30) days after the 38 Termination Date, Landlord shall return to Tenant the Security Deposit in the form of an original letter of credit issued by Silicon Valley Bank in the amount of $570,814.00.
Landlord acknowledges and agrees that Tenant may notify the issuer of such letter of credit that Tenant does not intend to renew such letter of credit after the 38 Termination Date, and provided that such letter of credit is not terminated prior to
thirty (30) days after the 38 Termination Date, Landlord acknowledges and agrees that no such action by Tenant, nor a receipt by Landlord of a letter of non-renewal from such issuer, shall constitute a default of Tenant under the 38 Lease or
this Agreement. 

	 	3.	Effective upon execution of this Agreement: (1) the 38 Lease shall be terminated effective as of the 38 Termination Date, and shall have no further force or effect, except as otherwise provided therein;
(2) Tenant shall have no obligation for the payment of Annual Fixed Rent or Additional Rent with respect to the 38 Lease from and after the 88 Rent Commencement Date; (3) Tenant shall surrender the Premises in accordance with the terms of
the 38 Lease; (4) Landlord shall release Tenant from the performance of the terms, covenants and conditions of the 38 Lease, except those that by their terms survive the expiration and/or earlier termination of the 38 Lease, including without
limitation, any amounts due Landlord as a result of the annual reconciliation of Operating Expenses and Real Estate Taxes, the Tenant’s obligation to remove any Hazardous Materials from the Premises as required by Section 6.1 and
Section 6.2, Tenant’s obligation to repair any damage to the Premises as required by Section 11.10 and any Tenant indemnification obligations under the 38 Lease; and (5) Tenant shall release Landlord from the performance of the terms,
covenants and conditions of the 38 Lease, except those that by their terms survive the expiration and/or earlier termination of the 38 Lease, including without limitation, any amounts due Tenant as a result of the annual reconciliation of Operating
Expenses and Real Estate Taxes and any Landlord indemnification obligations under the 38 Lease. Notwithstanding anything set forth in the 38 Lease to the contrary, Tenant shall not be obligated to remove the internal stairway connecting the second
and third floor of the Premises. 

  

	 	4.	Tenant hereby acknowledges and agrees that, as of the date of this Agreement, Landlord is not in default in the performance of its obligations under the 38 Lease, and, to the best of Tenant’s knowledge, no event
has occurred that, with the giving of notice or the passage of time or both, could constitute a default by Landlord under the 38 Lease. Landlord hereby acknowledges and agrees that, as of the date of this Agreement, Tenant is not in default in the
performance of its obligations under the 38 Lease, and, to the best of Landlord’s knowledge, no event has occurred that, with the giving of notice or the passage of time or both, could constitute a default by Tenant under the 38 Lease.

  

	 	5.	This Agreement may be executed in any number of counterparts, each of which shall be deemed an original and all of which together shall constitute one and the same instrument. 

 

	 	6.	This Agreement will be governed by and construed in accordance with the laws of the Commonwealth of Massachusetts. 

  
 2 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement under seal, as of the day,
month and year first above written. 
 LANDLORD: 

THIRTY-EIGHT SIDNEY STREET LIMITED PARTNERSHIP, 
 a Delaware
limited partnership 
  

			
	By:	 	 Forest City 38 Sidney Street, Inc.,
 an Ohio
corporation

		 	Its General Partner

  

					
		 	By:	 	 /s/ Michael Farley

		 	Name:	 	Michael Farley
		 	Title:	 	Vice President

 TENANT: 
 AGIOS
PHARAMACEUTICALS, INC., 
 a Delaware corporation 
  

			
	By:	 	 /s/ David Schenkein

	Name:	 	David Schenkein
	Title:	 	Chief Executive Officer

  
 3Exhibit 4.1

 

WAIVER
AND AMENDMENT AGREEMENT

 

THIS
WAIVER AND AMENDMENT AGREEMENT (this “Amendment”) is made and entered into as of September 18, 2014 (the “Execution
Date”), by and among Ener-Core, Inc., a Nevada corporation (the “Company”), and the undersigned holder
(the “Holder”). Capitalized terms used but not defined herein shall have the meanings set forth in the Warrant
(as defined in the Recitals below).

 

RECITALS:

 

WHEREAS,
reference is made to that certain Securities Purchase Agreement dated as of April 15, 2014, by and among the Company, the Holder
and the other investors (the "Other Holders") listed on the signature pages attached thereto (the "April
2014 SPA"), and the Warrant to purchase common stock issued to the Holder pursuant thereto (the “Warrant”);

 

WHEREAS,
the Company desires to enter into a financing transaction (the “September 2014 Financing”) in which it proposes
to issue: (a) up to $4 million in shares of its common stock, par value $0.0001 per share (the “Common Stock”),
to certain accredited investors at $0.15 per share (the “Purchase Price”), (b) an aggregate of up to 1,600,000
restricted shares of Common Stock to the placement agents that the Company engaged for the September 2014 Financing (the “Placement
Agents”), and (c) warrants for the purchase of a total of up to 1,800,000 shares of Common Stock, with an exercise price
of $0.50 per share to the Placement Agents (all as adjusted for any stock dividend, stock split, stock combination, reclassification
or similar transaction occurring after the Execution Date) (such issuances, collectively the “Issuance”), which
Issuance, if and when effectuated, would be deemed a Dilutive Issuance and thereby reduce the Exercise Price to be equal to the
Purchase Price (the “Anti-dilution Adjustment”); and

 

WHEREAS,
the Company has proposed that the Holder waive (i) the Anti-dilution Adjustment with respect to the Issuance in exchange for adjusting
the Exercise Price to $0.50 on the terms set forth below and (ii) the participation and notice rights set forth in Section 4(n)(iii)
of the April 2014 SPA (collectively, the “Proposal”), which Proposal is acceptable to the Holder; and

 

NOW,
THEREFORE, in consideration of the foregoing recitals and the mutual agreements herein contained and for other good and valuable
consideration, the parties hereto agree as follows:

 

A.              WAIVER
AND AMENDMENT.

 

(1)              Waivers.
Subject to Section (A)(4) below, the Holder agrees (a) that the Issuance to the Placement Agents and pursuant to the terms and
conditions of the Company’s Securities Purchase Agreement in the form of Exhibit A attached hereto shall not be deemed
to be a Dilutive Issuance, and hereby waives all rights under Section 2 of the Warrant solely with respect to such Issuance and
(b) to waive its rights set forth in Section 4(n)(iii) of the April 2014 SPA, including, without limitation, its right to notices
solely with respect to such Issuance.

 

    	 

    	 

    

 

(2)             Amendments.
Subject to Section (A)(4) below, the Company and the Holder agree that the Warrant held the such Holder as of the Execution Date
shall be amended as follows:

 

  (a)          Section
1(b) shall be amended and restated in its entirety to read as follows:

 

"Exercise
Price. For purposes of this Warrant, "Exercise Price" means $0.50, subject to adjustment as provided herein."

 

For
the avoidance of doubt, Section 1(b) of the Warrant is being amended and restated to provide for a reduction in the Exercise Price
pursuant to Section 2(b) of the Warrant since the Holder and the Other Holders constitute the Required Holders.

 

  (b)          Section
2 is amended to add the following subsection 2(e):

 

"(e)
March 2015 Exercise Price Reset. Provided that the Holder shall limit sales in the Company’s Common Stock during
the 10 Day Period (as defined below) to not more than twenty percent (20%) of the total number of shares of the Company’s
Common Stock issuable to the Holder upon exercise of its Warrant (without regard to any limitation or restriction on the exercise
thereof), on March 24, 2015 (the “Adjustment Date”), the Exercise Price then in effect shall be adjusted to
equal the lower of (i) the then effective Exercise Price and (ii) seventy percent (70%) of the Adjustment Exercise Price. As used
herein, the “Adjustment Exercise Price” shall equal the arithmetic average of the Weighted Average Prices of
the Common Stock for the ten (10) consecutive Trading Days immediately preceding the Adjustment Date (the “10 Day Period”),
such price rounded to the nearest $0.01 per share."

 

(3)              Except
as expressly set forth herein, this Amendment shall not be deemed to be a waiver, amendment or modification of any provisions
of the Warrant, or of any right, power or remedy of the Holder, or constitute a waiver, amendment or modification of any provision
of the Warrant (except to the extent explicitly set forth herein), or any other document, instrument and/or agreement executed
or delivered in connection therewith, in each case whether arising before or after the date hereof or as a result of performance
hereunder or thereunder, all of which (except as specified herein) remain in full force and effect. Except as explicitly set forth
herein, the Holder reserves all of its rights, remedies, powers, and privileges.

 

(4)              This
Amendment shall become effective when, and only when, the Company and the undersigned shall have executed and delivered this Amendment
and the Company and all Other Holders shall have executed and delivered one or more Amendments in form and substance identical
to this Amendment (the "Other Amendments").

 

    	-2-

    	 

    

 

B.               CONFLICTS.
Except as expressly set forth in this Amendment, the terms and provisions of the Warrant shall continue unmodified and in full
force and effect. In the event of any conflict between this Amendment and the Warrant, this Amendment shall control.

 

C.               GOVERNING
LAW. This Amendment shall be governed and construed under the laws of the State of New York, and shall be binding on and shall
inure to the benefit of the parties and their respective successors and permitted assigns.

 

D.               COUNTERPARTS.
This Amendment may be executed in any number of counterparts, each of which shall be an original, but all of which together shall
constitute one instrument. A facsimile or other electronic transmission of this signed Amendment shall be legal and binding on
all parties hereto.

 

E.               TERMINATION.
The Holder shall have the option to terminate this Amendment with respect to the Company at any time prior to the date that is
five (5) Business Days following the Execution Date without liability to the Company if the Other Holders have not executed and
delivered the Other Amendments prior to such time.

 

[Remainder
of page left blank intentionally]

 

    	-3-

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first set forth above.

 

COMPANY:

 

Ener-Core,
Inc.

 

	By:		 
	Name:	Alain
    J. Castro	 
	Title:	Chief
    Executive Officer	 

 

    	-4-

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first set forth above.

 

HOLDER:

 

	[HOLDER
    NAME]	 
	 	 	 
	By:		 
	 	 	 
	Name:		 
	 	 	 
	Title:		 

 

    	-5-

    	 

    

 

EXHIBIT
A

 

Form
of Securities Purchase Agreement

 

 

-6-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00235-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00235-of-00352.parquet"}]]